Skip to content

Clinical trials

Completed Phase 2 Retinal Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Diseases Phase: Phase 2 Status: Completed Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20073
20091
20102
20113
20131
20151
20191
20202
20212
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Neurotech Pharmaceuticals3
Unity Biotechnology, Inc.2
Adverum Biotechnologies, Inc.1
Alcon Research1
Alkahest, Inc.1
Allergan1
Bambino Gesù Hospital and Research Institute1
Chengdu University of Traditional Chinese Medicine1
Eye Center of Northern Colorado, P.C.1
Michael Mauer, MD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Diseases23
Eye Diseases11
Macular Edema6
Diabetes Mellitus5
Diabetic Retinopathy5
Retinal Degeneration5
Retinitis Pigmentosa5
Edema4
Macular Degeneration4
Eye Diseases, Hereditary2

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.